Immune monitoring for advanced cell therapy trials in transplantation: which assays and when?
A number of immune regulatory cellular therapies, including regulatory T cells and mesenchymal stromal cells, have emerged as novel alternative therapies for the control of transplant alloresponses. Clinical studies have demonstrated their feasibility and safety, however developing our understanding...
Үндсэн зохиолчид: | Stark, HL, Wang, HC, Kuburic, J, Alzhrani, A, Hester, J, Issa, F |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
Frontiers Media
2021
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Immune Monitoring for Advanced Cell Therapy Trials in Transplantation: Which Assays and When?
-н: Helen L. Stark, зэрэг
Хэвлэсэн: (2021-03-01) -
An exploration of regulatory T cells in transplantation: cell therapy development and immune monitoring
-н: Alzhrani, AI
Хэвлэсэн: (2021) -
Biomarkers and surrogates of acute rejection in vascularized composite allograft transplantation
-н: Honeyman, C, зэрэг
Хэвлэсэн: (2021) -
Biomarker and surrogate development in vascularised composite allograft transplantation: current progress and future challenges
-н: Honeyman, C, зэрэг
Хэвлэсэн: (2020) -
Immune Monitoring Assay for Extracorporeal Photopheresis Treatment Optimization After Heart Transplantation
-н: Maja-Theresa Dieterlen, зэрэг
Хэвлэсэн: (2021-08-01)